CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 
 

MRNA's EPS Net Growth by Quarter and Year

Moderna Inc 's EPS Net results by quarter and year




MRNA EPS Net (in $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -0.69 -0.41 0.37
III Quarter September - -0.59 -0.27 -0.69
II Quarter June 6.46 -0.31 -0.29 -0.43
I Quarter March 2.84 -0.35 -0.27 -0.13
FY   9.30 -1.94 -1.24 -0.88



MRNA EPS Net second quarter 2021 Y/Y Growth Comment
Moderna Inc in the second quarter achieved EPS Net of $ 6.46 compare to EPS net loss recorded in same quarter a year ago.

According to the results reported in the second quarter, Moderna Inc achieved the best EPS Net growth in Biotechnology & Pharmaceuticals industry. While Moderna Inc ' s EPS Net no change of % ranks overall at the positon no. 0 in the second quarter.




MRNA EPS Net ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Moderna Inc 's second quarter 2021 EPS Net $ 6.46 MRNA's Income Statement
Moderna Inc 's second quarter 2020 EPS Net $ -0.31 Quarterly MRNA's Income Statement
New: More MRNA's historic EPS Net Growth >>


MRNA EPS Net (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 127.46 % - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0

EPS Net Y/Y Growth Statistics
High Average Low
-91.68 % -95.84 % -100 %
(Dec 31 2015)   (Jun 30 2013)
EPS Net second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
EPS Net Y/Y Growth Statistics
High Average Low
-91.68 % -95.84 % -100 %
(Dec 31 2015)   (Jun 30 2013)

EPS Net by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Moderna Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
127.46 % 13.73 % -100 %
(Jun 30 2021)  


MRNA's II. Quarter Q/Q EPS Net Comment
Moderna Inc achieved in the II. Quarter 2021 above company average sequential EPS Net doubling of 127.46%, to $ 6.46 , from $2.84 in the first quarter.
Moderna Inc is undergoing a remarkable growth, with reporting above average increase, but also improving speed.

Within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher EPS Net quarter on quarter growth. While Moderna Inc 's EPS Net growth quarter on quarter, overall rank is 285.


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #21
Overall #285
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #21
Overall #285
EPS Net Q/Q Growth Statistics
High Average Low
127.46 % 13.73 % -100 %
(Jun 30 2021)  


MRNA's II. Quarter Q/Q EPS Net Comment
Moderna Inc achieved in the II. Quarter 2021 above company average sequential EPS Net doubling of 127.46%, to $ 6.46 , from $2.84 in the first quarter.
MRNA is impressively improving, with claiming above normal increase, and additionally improving rate.

Within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher EPS Net quarter on quarter growth. While Moderna Inc 's EPS Net growth quarter on quarter, overall rank is 285.


Moderna Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
Cumulative EPS Net 12 Months Ending $ 8.02 $ 1.25 $ -1.94 $ -1.66 $ -1.34
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) 540.02 % - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # 32 # 0 # 0 # 0 # 0




Cumulative EPS Net growth Comment
In the Jun 30 2021 period, Moderna Inc had cumulative twelve months EPS Net of $ 8 compare to EPS net loss of $ -1 a year ago.
Singns of recovery, but very slow one, recording less then standard 540.02 % EPS Net rise, from $1.25 from the period from Mar 31 2021 to Jun 30 2020 Cameron Taylor mentioned.

Moderna Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
540.02 %
540.02 %
540.02 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 3
S&P 500 # 32
Cumulative EPS Net growth Comment
In the Jun 30 2021 period, Moderna Inc had cumulative twelve months EPS Net of $ 8 compare to EPS net loss of $ -1 a year ago.
There is progress on the way, although with caution, recording below standard 540.02 % EPS Net rise, from $1.25 from the twelve months ending in the quarter Mar 31 2021.

Moderna Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
540.02 %
540.02 %
540.02 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 3
S&P 500 # 32




Other EPS Net Growth
Biotechnology & Pharmaceuticals Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
MRNA's EPS Net Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for MRNA's Competitors
EPS Net Growth for Moderna Inc 's Suppliers
EPS Net Growth for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Dividend Payout Ratio
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons



Companies with similar EPS Net doubling for the quarter ending Jun 30 2021 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Jun 30 2021
Eli Lilly And Company-1.29%$ -1.290 
Bio rad Laboratories Inc -5.69%$ -5.692 
Corcept Therapeutics Inc-8.70%$ -8.696 
Zynex Inc-11.11%$ -11.111 
Lhc Group Inc-16.08%$ -16.084 
U S Physical Therapy Inc-17.17%$ -17.172 
Reynolds Consumer Products Inc -28.30%$ -28.302 
Chemed Corporation-29.94%$ -29.940 
Msa Safety Inc-30.43%$ -30.435 
Supernus Pharmaceuticals inc -33.85%$ -33.846 
Co diagnostics Inc -35.29%$ -35.294 
The Pennant Group Inc -40.00%$ -40.000 
Petmed Express Inc-43.59%$ -43.590 
Neurocrine Biosciences Inc -46.91%$ -46.914 
Hill rom Holdings Inc -47.14%$ -47.143 
Merck and Co Inc -48.31%$ -48.305 
Incyte Corp-49.24%$ -49.242 
Healthcare Services Group Inc -58.06%$ -58.065 
Molecular Templates Inc -58.82%$ -58.824 
Meridian Bioscience Inc -59.38%$ -59.375 
Sunlink Health Systems Inc-60.42%$ -60.415 
Pro Dex Inc-66.22%$ -66.224 
Vyne Therapeutics Inc -67.77%$ -67.769 
Hanger inc -67.90%$ -67.901 
Biogen Inc -68.82%$ -68.822 
Electromed Inc -68.90%$ -68.904 
Tivity Health Inc -70.69%$ -70.690 
Quidel Corporation-70.97%$ -70.968 
Amgen Inc -73.44%$ -73.443 
Alpha Pro Tech Ltd-73.91%$ -73.913 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ULNV's Profile

Stock Price

ULNV's Financials

Business Description

Fundamentals

Charts & Quotes

ULNV's News

Suppliers

ULNV's Competitors

Customers & Markets

Economic Indicators

ULNV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071